Sökning: id:"swepub:oai:gup.ub.gu.se/302679" >
Laboratory diagnost...
Laboratory diagnostic value of neopterin measurements in patients with COVID-19 infection
-
Fuchs, D. (författare)
-
- Gisslén, Magnus, 1962 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine
-
(creator_code:org_t)
- 2021-01-29
- 2021
- Engelska.
-
Ingår i: Pteridines. - : Walter de Gruyter GmbH. - 0933-4807 .- 2195-4720. ; 32:1, s. 1-4
- Relaterad länk:
-
https://www.degruyte...
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- The new coronavirus SARS-CoV-2 was identified to be responsible for the COVID-19 pandemic. There are striking differences in the response to infection, some people develop no or mild symptoms, while other outcomes are severe of even fatal. For those COVID-19 patients who require hospitalization, prognostic markers could help clinicians to identify patients with a poor outcome early. The serum levels of the immune activation marker neopterin have already been shown to be of prognostic value in patients with SARS-CoV-1 and a similar pattern can be observed for SARS-CoV-2. This comment discusses the biochemical circuits that support the clinical value of neopterin measurements in COVID-19 patients.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
Nyckelord
- COVID-19
- Neopterin
- Laboratory diagnostic
- serum neopterin
- metabolism
- tryptophan
- marker
- Biochemistry & Molecular Biology
- Biophysics
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas